Archive: November 2023
Feature
Recent Approaches in Portal Hypertension Involving Risk Stratification and Medical Management
Abstract: Portal hypertension leads to the formation of portosystemic collaterals that divert portal blood to the systemic circulation and bypass the liver, resulting in multiple severe […]
Feature
Hepatitis C Virus Elimination in the United States: Challenges, Progress, and Future Steps
Abstract: Hepatitis C virus (HCV) infection is a major public health challenge with a simple, highly efficacious, all-oral therapy (direct-acting antivirals) that can achieve cure. Owing […]
Feature
Dietary Management of Eosinophilic Esophagitis
Abstract: Eosinophilic esophagitis (EoE) is a chronic immune-mediated food antigen–driven disease characterized by tissue eosinophilia and clinical symptoms of esophageal dysfunction. Medical and dietary therapies can […]
Advances in MASH
Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH
G&H Why was the nomenclature for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis changed? MR From a historical perspective, the terms nonalcoholic fatty liver disease (NAFLD) […]
Advances in IBD
Exploring the Early-Life Microbiome and Future Risk of Inflammatory Bowel Disease
G&H What are the biggest early-life risk factors for inflammatory bowel disease overall? SN Many studies have looked at risk factors for the development of inflammatory […]
Advances in IBS
New Developments and the Role of Gravity in the Pathogenesis of Irritable Bowel Syndrome
G&H How did the idea of gravity playing a role in irritable bowel syndrome come about? BS It began after contemplating a family member who has […]
Letter From the Editor
Letter From the Editor: Spotlight on Hepatology
In anticipation of the upcoming Liver Meeting, being held in Boston, Massachusetts in November, this month’s issue of Gastroenterology & Hepatology shines a spotlight on hepatology. […]